Business
Anthropic’s Drug Discovery Dreams: ‘It Is Not A Side Effort’
▲ Sign in to vote stories up
Coverage 1 source · 1 report
Chronological — read the same story from every side and decide for yourself.
-
Anthropic’s Drug Discovery Dreams: ‘It Is Not A Side Effort’
Anthropic’s recent purchase of one-man firm Mithril is just the tip of the spear in how it hopes to use AI to accelerate drug development as it seeks a $1.4 trillion valuation in the public markets.
Discussion 0 comments